A citation-based method for searching scientific literature

Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
Times Cited: 83







List of co-cited articles
358 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic testing in cancer: patient knowledge, attitudes, and expectations.
Phillip S Blanchette, Anna Spreafico, Fiona A Miller, Kelvin Chan, Jessica Bytautas, Steve Kang, Philippe L Bedard, Andrea Eisen, Larissa Potanina, Jack Holland,[...]. Cancer 2014
59
44

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
67
37

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
152
20

Attitudes toward molecular testing for personalized cancer therapy.
Rafeek A Yusuf, Deevakar Rogith, Shelly R A Hovick, Susan K Peterson, Allison M Burton-Chase, Bryan M Fellman, Yisheng Li, Carolyn McKinney, Elmer V Bernstam, Funda Meric-Bernstam. Cancer 2015
40
40

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
15

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
327
14

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
77
14

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
12

Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.
R Liang, B Meiser, S Smith, N A Kasparian, C R Lewis, M Chin, G V Long, R Ward, A M Menzies, J N Harris-Wai,[...]. Eur J Cancer Care (Engl) 2017
14
64

Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Melinda L Yushak, Gang Han, Sara Bouberhan, Lianne Epstein, Michael P DiGiovanna, Sarah S Mougalian, Tara B Sanft, Maysa M Abu-Khalaf, Gina G Chung, Stacey M Stein,[...]. Cancer 2016
34
23

Clinical analysis and interpretation of cancer genome data.
Eliezer M Van Allen, Nikhil Wagle, Mia A Levy. J Clin Oncol 2013
94
8

Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing.
Sinead Cuffe, Henrique Hon, Xin Qiu, Kimberly Tobros, Chung-Kwun Amy Wong, Bradley De Souza, Graham McFarlane, Sohaib Masroor, Abul K Azad, Ekta Hasani,[...]. Pharmacogenet Genomics 2014
23
30

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
Rajen J Mody, Yi-Mi Wu, Robert J Lonigro, Xuhong Cao, Sameek Roychowdhury, Pankaj Vats, Kevin M Frank, John R Prensner, Irfan Asangani, Nallasivam Palanisamy,[...]. JAMA 2015
243
8

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
187
8

Patient knowledge and information-seeking about personalized cancer therapy.
Deevakar Rogith, Rafeek A Yusuf, Shelley R Hovick, Bryan M Fellman, Susan K Peterson, Allison M Burton-Chase, Yisheng Li, Elmer V Bernstam, Funda Meric-Bernstam. Int J Med Inform 2016
16
43

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
936
8

Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
Jada G Hamilton, Elyse Shuk, Margaux C Genoff, Vivian M Rodríguez, Jennifer L Hay, Kenneth Offit, Mark E Robson. J Oncol Pract 2017
21
33

Next-generation sequencing in precision oncology: Patient understanding and expectations.
J Scott Roberts, Michele C Gornick, Lan Q Le, Natalie J Bartnik, Brian J Zikmund-Fisher, Arul M Chinnaiyan. Cancer Med 2019
22
31


Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.
Funda Meric-Bernstam, Lauren Brusco, Kenna Shaw, Chacha Horombe, Scott Kopetz, Michael A Davies, Mark Routbort, Sarina A Piha-Paul, Filip Janku, Naoto Ueno,[...]. J Clin Oncol 2015
285
7

Tumor genome analysis includes germline genome: are we ready for surprises?
Daniel V T Catenacci, Andrea L Amico, Sarah M Nielsen, Daniel M Geynisman, Brittany Rambo, George B Carey, Cassandra Gulden, Jim Fackenthal, Robert D Marsh, Hedy L Kindler,[...]. Int J Cancer 2015
57
10

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Tracy L Stockley, Amit M Oza, Hal K Berman, Natasha B Leighl, Jennifer J Knox, Frances A Shepherd, Eric X Chen, Monika K Krzyzanowska, Neesha Dhani, Anthony M Joshua,[...]. Genome Med 2016
145
7


Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes.
I Pellegrini, M Rapti, J-M Extra, A Petri-Cal, T Apostolidis, J-M Ferrero, T Bachelot, P Viens, C Julian-Reynier, F Bertucci. Eur J Cancer Care (Engl) 2012
22
27

Women's experiences with genomic testing for breast cancer recurrence risk.
Janice P Tzeng, Deborah Mayer, Alice R Richman, Isaac Lipkus, Paul K Han, Carmina G Valle, Lisa A Carey, Noel T Brewer. Cancer 2010
43
11


Knowledge of genomic testing among early-stage breast cancer patients.
Alice R Richman, Janice P Tzeng, Lisa A Carey, Valesca P Retèl, Noel T Brewer. Psychooncology 2011
32
15

Assessing patient readiness for the clinical adoption of personalized medicine.
A M Issa, W Tufail, J Hutchinson, J Tenorio, M Poonam Baliga. Public Health Genomics 2009
42
11

Australian study on public knowledge of human genetics and health.
C Molster, T Charles, A Samanek, P O'Leary. Public Health Genomics 2009
82
6

Effects of informed consent for individual genome sequencing on relevant knowledge.
K A Kaphingst, F M Facio, M-R Cheng, S Brooks, H Eidem, A Linn, B B Biesecker, L G Biesecker. Clin Genet 2012
83
6


Precision medicine--personalized, problematic, and promising.
J Larry Jameson, Dan L Longo. N Engl J Med 2015
529
6

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
6

Recommendations for returning genomic incidental findings? We need to talk!
Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, Jeffrey Botkin, Ellen Wright Clayton, Gail E Henderson, Ingrid A Holm, Gail P Jarvik, Muin J Khoury, Bartha Maria Knoppers,[...]. Genet Med 2013
218
6

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
228
6

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita,[...]. N Engl J Med 2010
4

The genetic basis for cancer treatment decisions.
Janet E Dancey, Philippe L Bedard, Nicole Onetto, Thomas J Hudson. Cell 2012
202
4

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
Carmen J Allegra, J Milburn Jessup, Mark R Somerfield, Stanley R Hamilton, Elizabeth H Hammond, Daniel F Hayes, Pamela K McAllister, Roscoe F Morton, Richard L Schilsky. J Clin Oncol 2009
912
4

Knowledge about genomic recurrence risk testing among breast cancer survivors.
Isaac M Lipkus, Susan T Vadaparampil, Paul B Jacobsen, Cheryl A Miree. J Cancer Educ 2011
18
22

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
300
4

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
4

Clinical implications of the cancer genome.
Laura E Macconaill, Levi A Garraway. J Clin Oncol 2010
132
4

Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.
Martijn P Lolkema, Christa G Gadellaa-van Hooijdonk, Annelien L Bredenoord, Peter Kapitein, Nancy Roach, Edwin Cuppen, Nine V Knoers, Emile E Voest. J Clin Oncol 2013
66
6

Communicating genetic and genomic information: health literacy and numeracy considerations.
D H Lea, K A Kaphingst, D Bowen, I Lipkus, D W Hadley. Public Health Genomics 2011
146
4

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
D J Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram,[...]. N Engl J Med 2001
4

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).
Fabrice André, Thomas Bachelot, Frederic Commo, Mario Campone, Monica Arnedos, Véronique Dieras, Magali Lacroix-Triki, Ludovic Lacroix, Pascale Cohen, David Gentien,[...]. Lancet Oncol 2014
271
4

Personalized oncology through integrative high-throughput sequencing: a pilot study.
Sameek Roychowdhury, Matthew K Iyer, Dan R Robinson, Robert J Lonigro, Yi-Mi Wu, Xuhong Cao, Shanker Kalyana-Sundaram, Lee Sam, O Alejandro Balbin, Michael J Quist,[...]. Sci Transl Med 2011
432
4

'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.
S Daack-Hirsch, M Driessnack, A Hanish, V A Johnson, L L Shah, C M Simon, J K Williams. Clin Genet 2013
51
7


Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
349
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.